A GLOBAL COMPANY INTEGRATED IN THE ANIMAL AND HUMAN HEALTH INDUSTRIES WITH A DIVERSIFIED PORTFOLIO OF PRODUCTS AND BUSINESSES AND A BROAD CLIENT BASE OF TOP-TIER CUSTOMERS WITH WHOM IT HAS A LONG-LASTING TRUSTED RELATIONSHIP.
OTHER RELEVANT INFORMATION
14/02/2025 LABIANA Otra Información Relevante: Operaciones realizadas por directivos. LABIANA informa sobre el detalle de las operaciones de compra de acciones de LABIANA realizadas por ORTEGA FARMING S.L.U., representada por D. Manuel Ramos Ortega, Consejero Delegado de LABIANA, el 11 de febrero de 2025. Ver pdf. (107 KB)
10/02/2025 LABIANA Otra Información Relevante: Programas de recompra de acciones, estabilización y autocartera. LABIANA informa sobre el detalle de las operaciones de compra de acciones propias por parte de LABIANA, realizadas en el periodo comprendido entre el 3 de febrero de 2025 y el 7 de febrero de 2025, en ejecución del Programa de Recompra de Acciones Propias aprobado por el Consejo de Administración en sesión de 23 de octubre de 2024. Ver pdf. (124 KB)
07/02/2025 LABIANA Otra Información Relevante: Operaciones realizadas por directivos. LABIANA informa sobre el detalle de las operaciones de compra de acciones de LABIANA realizadas por ORTEGA FARMING S.L.U., representada por D. Manuel Ramos Ortega, Consejero Delegado de LABIANA, entre el 4 y el 5 de febrero de 2025. Ver pdf. (108 KB)
31/01/2025 LABIANA Otra Información Relevante: Operaciones realizadas por directivos. LABIANA informa sobre el detalle de las operaciones de compra de acciones de LABIANA realizadas por Sandra Villagrasa Clemente, Directora General de LABIANA, el 28 de enero de 2025. Ver pdf. (146 KB)
———- View more ———-
22/12/2023 LABIANA Other Relevant Information: Share buyback programs, stabilization, and treasury stock. LABIANA communicates the details of the share buyback transactions carried out by the Company between December 21, 2023, and December 22, 2023, in execution of the Share Buyback Program approved by the Board of Directors in the session of September 25, 2023. Ver pdf (135 KB)
22/12/2023 LABIANA Other Relevant Information: Other relevant information. The Company reports the agreements adopted at the Extraordinary General Shareholders’ Meeting held on December 22, 2023.. Ver pdf (235 KB)
19/12/2023 LABIANA Other Relevant Information: Share buyback programs, stabilization, and treasury stock. LABIANA reports the details of the share buyback transactions carried out by the Company on December 15, 2023, in execution of the Share Buyback Program approved by the Board of Directors in the session of September 25, 2023. Ver pdf (132 KB)
23/11/2023 LABIANA Other Relevant Information: Call for a Meeting or Assembly. According to the OIR published by LABIANA on November 22, 2023, the company announced that by agreement of the Board of Directors of LABIANA, the shareholders are summoned to the Extraordinary General Meeting of Shareholders, to be held on December 22, 2023. Ver pdf (183 KB)
———- Ver más ———-
31/10/2022 LABIANA OTHER RELEVANT INFORMATION: Information on forecasts published on October 28, 2022. Ver pdf (140 KB)
31/10/2022 LABIANA OTHER RELEVANT INFORMATION: Labiana announces the launch of a new veterinary medicine. Ver pdf (344 KB)
28/10/2022 LABIANA OTHER RELEVANT INFORMATION: Communication of future update of comparative figures for 2021 in the profit and loss account. Ver pdf (104 KB)
28/10/2022 LABIANA OTHER RELEVANT INFORMATION: Semiannual financial and audit/review reports. Financial information for the first half of 2022. Ver pdf (17 MB)
———- Ver más ———-
INVESTOR RELATIONS
Avenida Europa, 34 1ºD
28023 Pozuelo de Alarcón (Madrid)
Phone: (+34) 91 991 26 28
